117 related articles for article (PubMed ID: 873621)
21. Increased B Regulatory Phenotype in Non-Metastatic Lymph Nodes of Node-Positive Breast Cancer Patients.
Mehdipour F; Razmkhah M; Hosseini A; Bagheri M; Safaei A; Talei AR; Ghaderi A
Scand J Immunol; 2016 Mar; 83(3):195-202. PubMed ID: 26708831
[TBL] [Abstract][Full Text] [Related]
22. [Interferon production in lymph nodes draining breast carcinoma and its augmentation by OK-432].
Nakajima Y; Akimoto M; Kimura M; Matano S; Hirakawa H; Kasai M
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2766-71. PubMed ID: 2428312
[TBL] [Abstract][Full Text] [Related]
23. Lymphocyte anergy in patients with carcinoma.
Nind AP; Nairn RC; Rolland JM; Guli EP; Hughes ES
Br J Cancer; 1973 Aug; 28(2):108-17. PubMed ID: 4581078
[TBL] [Abstract][Full Text] [Related]
24. Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes.
Faghih Z; Erfani N; Haghshenas MR; Safaei A; Talei AR; Ghaderi A
Immunol Lett; 2014; 158(1-2):57-65. PubMed ID: 24326038
[TBL] [Abstract][Full Text] [Related]
25. Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women.
Cunningham-Rundles S; Filippa DA; Braun DW; Antonelli P; Ashikari H
J Natl Cancer Inst; 1981 Sep; 67(3):585-90. PubMed ID: 6944530
[TBL] [Abstract][Full Text] [Related]
26. Similarities of Fc receptors in human malignant tissue and normal lymphoid tissue.
Tonder O; Morse PA; Humphrey LJ
J Immunol; 1974 Oct; 113(4):1162-9. PubMed ID: 4472307
[No Abstract] [Full Text] [Related]
27. Correlation of regional lymph node in vitro antitumor immunoreactivity histology with colorectal carcinoma.
Pihl E; Nairn RC; Nind AP; Muller HK; Hughes ES; Cuthbertson AM; Rollo AJ
Cancer Res; 1976 Oct; 36(10):3665-71. PubMed ID: 1085194
[TBL] [Abstract][Full Text] [Related]
28. Functional character and augmentation of lymphocytes in regional lymph nodes of patients with lung cancer.
Watanabe Y; Hashizume Y; Shimizu J; Yoshida M; Watanabe S; Iwa T; Sakai S; Migita S; Sato H; Murayama T
Am Rev Respir Dis; 1990 Oct; 142(4):769-74. PubMed ID: 2221581
[TBL] [Abstract][Full Text] [Related]
29. Tumour-associated proliferative responses in vitro of regional lymph nodes draining solid cancers in man.
Mainou-Fowler T; Eremin O
Cancer Immunol Immunother; 1989; 30(5):300-6. PubMed ID: 2533881
[TBL] [Abstract][Full Text] [Related]
30. Axillary lymph-node and breast carcinoma interrelations in organ culture.
Kiricuta I; Todorutiu C; Mulea R; Risca R
Cancer; 1978 Dec; 42(6):2710-5. PubMed ID: 728869
[TBL] [Abstract][Full Text] [Related]
31. Lymphocyte traffic through antigen-stimulated lymph nodes. I. Complement activation within lymph nodes initiates cell shutdown.
McConnell I; Hopkins J
Immunology; 1981 Feb; 42(2):217-23. PubMed ID: 6906330
[TBL] [Abstract][Full Text] [Related]
32. Role of the regional lymph node in neoplasia: cellular mediated reactivity in vitro by autologous regional or distant lymph nodes or peripheral blood lymphocytes of dogs with spontaneous neoplasms.
Fidler IJ; McWilliams RW; Bech-Nielsen S; Budmen MB
Immunol Commun; 1975; 4(4):325-35. PubMed ID: 1184114
[TBL] [Abstract][Full Text] [Related]
33. Preservation of in vitro biological functions in regional lymph node lymphocytes in squamous head and neck cancer.
Saxon A; Portaro J
Cancer Res; 1977 Apr; 37(4):1159-64. PubMed ID: 139203
[TBL] [Abstract][Full Text] [Related]
34. [The role of the body's defense against tumors by regional lymph nodes].
Sakakibara N; Ogawa K; Yagawa H; Ohtani Y; Kawata H
Nihon Geka Gakkai Zasshi; 1985 Sep; 86(9):1116-9. PubMed ID: 4088223
[TBL] [Abstract][Full Text] [Related]
35. The relationship between cytotoxicity and prognostically significant histologic changes in lymph nodes from patients with cancer of the breast.
Check IJ; Cobb M; Hunter RL
Am J Pathol; 1980 Feb; 98(2):325-38. PubMed ID: 6243870
[TBL] [Abstract][Full Text] [Related]
36. The immune reactivity of the regional and distant lymph nodes to autochthonous ovine squamous cell carcinomata.
Al-Yaman FM; Willenborg DO
Vet Immunol Immunopathol; 1985 Jul; 9(3):261-72. PubMed ID: 4035980
[TBL] [Abstract][Full Text] [Related]
37. Lymphocyte migration during the development of regional lymph node anergy in experimental tumor growth.
Kimpton WG; McKenzie GA; Muller HK; Ruby JC; Poskitt DC
Cell Immunol; 1983 Jan; 75(1):13-21. PubMed ID: 6825181
[TBL] [Abstract][Full Text] [Related]
38. Variations in functional immunocompetence of individual tumor-draining lymph nodes in humans.
Hoon DS; Korn EL; Cochran AJ
Cancer Res; 1987 Mar; 47(6):1740-4. PubMed ID: 3493068
[TBL] [Abstract][Full Text] [Related]
39. Memory CD4
Vahidi Y; Faghih Z; Talei AR; Doroudchi M; Ghaderi A
Cell Oncol (Dordr); 2018 Feb; 41(1):1-11. PubMed ID: 28994018
[TBL] [Abstract][Full Text] [Related]
40. Hierarchical immunosuppression of regional lymph nodes in patients with head and neck squamous cell carcinoma.
Wang MB; Lichtenstein A; Mickel RA
Otolaryngol Head Neck Surg; 1991 Oct; 105(4):517-27. PubMed ID: 1762790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
